The EU Fee president boasted Brussels’ generosity on Twitter in a swipe at different international locations exterior the bloc who refused to export vaccines earlier than guaranteeing their populations had been protected. Ms von der Leyen bragged about agreeing to provide away half of the 600 million vaccine doses produced within the EU to non-EU international locations.
She wrote: “Out of 600 million doses produced in Europe, about 300 million have been exported to over 90 international locations till now.
“If all the opposite vaccine producers had adopted our instance, the world at present could be a unique place.”
However the tweet backfired as livid French Nationwide Rally MEPs argued the Fee chief put the remainder of the world earlier than EU residents’ well being.
French MEP Jean-Lin Lacapelle stated: “After the vaccine negotiation fiasco, the European Union, but far behind in its vaccination marketing campaign, and von der Leyen are happy to have exported 300 of the 600 million doses produced in Europe.
“The remaining at all times comes earlier than our personal!
“That is their credo…”
Nationwide Rally MEP Julie Lechanteux additionally blasted the Fee chief on Twitter.
She wrote: “The EU’s globalist credo in impact: 300 of the 600 million doses produced in Europe had been exported to 90 international locations and @vonderleyen is happy…
“Frequent sense says these doses ought to go primarily to Europeans, however the European Fee has no frequent sense!”
Echoing their sentiment, MEP Jerome Riviere additionally added: “EU international locations behind of their vaccination programme.
The decision says solely a fraction of the 11 billion pictures wanted to vaccinate 70% of the world’s inhabitants has been produced and that counting on pledges of extra doses from richer nations will not be sufficient.
The textual content says that worldwide commerce coverage must play a task in facilitating commerce and revisiting international IP guidelines.
South Africa and India have been urgent for eight months on the World Commerce Group (WTO) for a short lived waiver of IP rights that might enable extra producers to provide pictures.
Developed nations dwelling to giant pharmaceutical corporations, together with the European Union, have resisted, arguing a waiver wouldn’t increase manufacturing and will undermine future analysis and improvement on vaccines and therapeutics.
The non-binding decision will increase stress on the European Fee to be constructive in WTO negotiations.
Nevertheless, it’s unlikely to alter its view that one of the best and quickest technique to enhance manufacturing is to make use of the pliability of present IP guidelines, because it has proposed on the WTO.
The Fee, which oversees EU commerce coverage, stated it was not satisfied a waiver was the best choice.
The decision additionally places lawmakers at odds with European Council president Charles Michel, who stated a patent waiver was “not a silver bullet”.
The European Parliament decision requires assist of “proactive, constructive and text-based negotiations” for the non permanent waiver.
The textual content can be despatched to the Fee, the Council, to all EU governments and parliaments, to the pinnacle of the World Commerce Group, G20 governments and different worldwide establishments.
The decision additionally says it regrets strikes by Britain and the USA to create a re-sale market to promote surplus vaccines to different industrialised international locations and urges each to abolish export restrictions on vaccines and their required uncooked supplies.
Further reporting by Maria Ortega